Experience
AbbVie Inc. et al
Alvotech hf.
Represented AbbVie Inc. in Biologics Price Competition and Innovation (BPCIA) litigation related to Humira®
AbbVie Inc. et al v. Alvotech hf., 1:21-cv-02258, 1:21-cv-02899, N.D. Ill., Judge Lee
AbbVie Inc.
Genzyme Corporation et al. v. Novartis Gene Therapies, Inc. et al.
Novartis Gene Therapies, Inc. et al.
Certain Adalimumab, Processes for Manufacturing or Relating to Same, and Products Containing Same
AbbVie Inc. et al
Abbott Laboratories v. Teva Pharmaceuticals USA, Inc.
Abbott Laboratories
Novartis Pharmaceuticals Corporation et al. v. Fresenius Kabi USA, LLC et al.
Novartis Pharmaceuticals Corporation et al.
Aerin Medical Inc. et al. v. Neurent Medical Inc. et al.
Aerin Medical Inc. et al.
Regenxbio, Inc. et al. v. Sarepta Therapeutics, Inc. et al.
Sarepta Therapeutics, Inc. et al.
Boston Scientific Corp. et al. v. Cook, Inc. et al.
Boston Scientific Corp. et al.
Grünenthal GmbH et al. v. Alvogen Pine Brook, Inc. et al.
Grünenthal GmbH et al.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.